Quantum Dot Light-Emitting Devices with Hydrogen-Bonded Interfaces

The patent changes the chemical parameter of the ligand groups at the interface. The quantum dot layer uses lipophilic groups (e.g., oleic acid, oleylamine) during manufacturing for good solvent compatibility, while the electron transport layer uses hydrophilic groups. This parameter change enables both layers to be manufactured with appropriate solvent systems while maintaining distinct chemical characteristics for subsequent interface modification.

The patent introduces an intermediary mechanism through illumination-induced decomposition. UV or visible light acts as the intermediary that transforms the lipophilic groups on the quantum dot surface into hydrophilic groups (carboxyl, carbonyl, hydroxyl). This intermediary process creates a transition zone at the interface that is compatible with both the quantum dot layer and the hydrophilic electron transport layer, resolving the affinity mismatch.

The patent applies preliminary action by pre-equipping the quantum dot layer with lipophilic groups that are specifically designed to be convertible. These groups (containing photosensitive moieties) are prepared in advance during quantum dot synthesis, setting up the system for subsequent light-induced transformation. This preliminary configuration enables the interface affinity improvement without requiring complete redesign of the quantum dot structure.

The patent replaces mechanical or chemical modification methods with optical field action. Instead of using complex chemical treatments, solvents, or thermal processes to modify the quantum dot surface, the invention uses illumination (UV or visible light) to induce decomposition and transformation of the ligand groups. This substitution simplifies the manufacturing process by replacing multiple mechanical/chemical steps with a single optical treatment step.

The patent changes the energy parameter by selecting photosensitive groups with appropriate absorption characteristics. The lipophilic groups are chosen to absorb UV or visible light at wavelengths that can be provided by conventional light sources, enabling the transformation at reasonable energy levels. This parameter optimization balances the energy input required for decomposition with the resulting interface bonding improvement.

The patent converts the potentially harmful effect of requiring additional energy input into a beneficial process. The illumination energy, which initially appears as an extra cost, actually serves dual purposes: it decomposes the lipophilic groups to create hydrophilic interface groups for better bonding, and simultaneously activates the photosensitive moieties to drive the chemical transformation. The energy input is thus converted into a beneficial chemical modification that improves device reliability.